Valeant to Hold Conference Call With CEO, Board Members

Valeant Under Scrutiny, Veritas Searches for Truth

Valeant Pharmaceuticals International Inc. will hold a conference call Monday with Chief Executive Officer Michael Pearson and members of the board’s audit and risk committee, the company said.

Present will be Pearson, the company’s top executives, and five members of the company’s board, Valeant said in a statement. The drugmaker’s stock has plummeted this week after a short seller published a report alleging that Valeant had improperly recorded sales. Valeant has denied those reports.

Before it's here, it's on the Bloomberg Terminal.